sigmalogo

AOD 9604 2mg

132 customer reviews

$23.50

AOD 9604 2mg

Availability: Expedited shipping if ordered and paid by 12 PM MT

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Description

AOD 9604: A History and Overview

AOD 9604, a synthetic peptide derived from the C-terminal fragment of human growth hormone (HGH), has sparked considerable interest in the fields of weight loss and medical research. Unlike HGH, which can promote muscle growth and carry a risk of side effects such as increased blood sugar levels, AOD 9604 focuses exclusively on fat burning. This specificity makes it a compelling candidate for those seeking weight loss solutions without the broader systemic effects of HGH.

AOD 9604 Chemical Composition

  • Chemical Name: AOD-9604 is also known as Tyr-hGH Frag 176-191, indicating its sequence within human growth hormone.
  • Synonyms: AOD 9604;polypeptide AOD 9604;peptides AOD9604;L-Phenylalanine, L-tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-α-glutamylglycyl-L-seryl-L-cysteinylglycyl-, cyclic (7→14)-disulfide;Injectable Lyophillzed Powder Peptides Peptide Aod-9604 Aod9604 Aod 9604 2mg/Vial;HGH frag 176-191 Oxidized;AOD 9604 acetate;Fragment 177-191
  • Molecular Formula: C78H123N23O23S2
  • Molecular Weight: Approximately 1815.08 g/mol
  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
  • Amino Acid Count: 16, representing a specific fragment (amino acids 176-191) of the human growth hormone.
  • CAS Number: 221231-10-3
  • Biological Half-life: AOD-9604 has a relatively short half-life, similar to other peptides, necessitating careful consideration in dosing schedules for therapeutic use.
  • Function: It is designed to mimic the lipolytic (fat-burning) region of human growth hormone without exhibiting its other hormonal effects. AOD-9604 is believed to stimulate the breakdown of fat and prevent the transformation of fatty food materials into body fat.
  • Use: Primarily researched for its potential in obesity treatment, weight management, and performance enhancement in sports. AOD-9604 has been investigated for its ability to reduce body fat in clinical settings.
  • Administration: It is usually administered via subcutaneous injection, though oral forms have been explored.
  • Pharmacokinetics: As a peptide, AOD-9604 exhibits pharmacokinetic properties typical of small proteins, including rapid absorption and elimination from the body, necessitating dosing considerations for therapeutic efficacy.
  • Regulatory Status: While AOD-9604 has been subject to clinical trials and research, its approval status varies by jurisdiction, and it is not widely approved for medical use.
  • Shelf Life: 36 months
  • Appearance: White lipolyzed powder puck.

AOD 9604Origins and Mechanism

AOD 9604 was developed in an effort to harness the fat-burning power of HGH without its anabolic effects and side effects. It targets fat cells directly, promoting lipolysis—the breakdown of fat—while inhibiting lipogenesis, the process by which foods are converted into body fat​​. This dual action is particularly appealing for its potential to address obesity without impacting blood sugar levels or insulin sensitivity, a significant advantage over other weight management strategies.

Clinical Trials and Efficacy

The journey of AOD 9604 from concept to clinical evaluation has been marked by several studies aimed at validating its efficacy and safety. Initial research highlighted its ability to stimulate lipolysis and reduce body fat in preclinical models. However, human clinical trials have yielded mixed results. A series of double-blind, placebo-controlled trials encompassing around 900 clinically obese subjects did not consistently demonstrate a significant reduction in body weight, prompting a reevaluation of its effectiveness as an anti-obesity agent​​.

Despite these varied outcomes, AOD 9604 has been shown to have an excellent safety profile, with no significant adverse effects on carbohydrate metabolism or growth factor levels, which are common concerns with HGH therapy​​​​.

Administration and Dosage

AOD 9604 can be administered orally or through subcutaneous injection, with a common dosage of 300 mcg per day. Its ease of use and the absence of serious side effects make it a viable option for those looking to reduce body fat. Nonetheless, individuals considering AOD 9604 should consult healthcare professionals to tailor the treatment to their specific needs and to monitor for any potential adverse reactions​​​​.

Legal and Doping Considerations

Athletes and bodybuilders interested in AOD 9604 should be aware of its status with the World Anti-Doping Agency (WADA), which lists it as a prohibited substance. This classification underscores the importance of understanding the regulatory landscape, especially for those in competitive sports​​.

Beyond Weight Loss: Potential Therapeutic Applications

Beyond its initial scope for weight management, AOD 9604 has shown promise in other therapeutic areas, such as bone and cartilage repair. These potential applications suggest a broader utility for the peptide in medical science, warranting further investigation​​​​.

Conclusion

AOD 9604 represents a novel approach to weight loss, with a mechanism distinct from traditional fat-burning agents. While it may not be a standalone solution for obesity, its safety profile and potential benefits make it a noteworthy complement to lifestyle interventions. As research continues, the future of AOD 9604 may expand into new therapeutic domains, offering hope for diverse patient populations seeking safe and effective treatment options.

Referenced Citations

  1. Detection and in vitro metabolism of AOD9604
    (https://pubmed.ncbi.nlm.nih.gov/25212235/)
  2. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
    (https://pubmed.ncbi.nlm.nih.gov/11500984/)
  3. The effects of human GH and its lipolytic fragment (AOD9604) on weight loss and lipolytic sensitivity. (https://pubmed.ncbi.nlm.nih.gov/12788493/)
  4. Effect of Intra-articular Injection of AOD9604 with or without hyaluronic acid in a knee osteoarthritis model. (https://pubmed.ncbi.nlm.nih.gov/31752577/)
  5. AOD-9604 Metabolic
    (https://pubmed.ncbi.nlm.nih.gov/15134286/)
  6. Analytical approaches for the detection of emerging drugs including AOD-9604 in doping analysis (https://pubmed.ncbi.nlm.nih.gov/23386327/)
  7. AOD-9604 does not influence the WADA hGH isoform immunoassay
    (https://pubmed.ncbi.nlm.nih.gov/24124018/)
  8. Effects of oral administration of a synthetic fragment of human growth hormone
    (https://pubmed.ncbi.nlm.nih.gov/9263273/)
  9. Identification and characterization of peptide drugs including AOD9604 in unknown pharmaceutical preparations. (https://pubmed.ncbi.nlm.nih.gov/30311976/)
  10. Increase of fat oxidation and weight loss in obese mice caused by AOD9604
    (https://pubmed.ncbi.nlm.nih.gov/12001183/)
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Recently Viewed Products

You haven't viewed at any of the products yet.

You’re reviewing:  

Be the first to know

Receive all the latest information on events, sales, & offers.